EGM
Engineers Gate Manager Portfolio holdings
AUM
$8.04B
1-Year Return
12.21%
This Quarter Return
+2.6%
1 Year Return
+12.21%
3 Year Return
+28.21%
5 Year Return
+42.98%
10 Year Return
+180.06%
AUM
$5.75B
AUM Growth
+$622M
(+12%)
Cap. Flow
+$579M
Cap. Flow
% of AUM
10.08%
Top 10 Holdings %
Top 10 Hldgs %
7.33%
Holding
2,680
New
612
Increased
791
Reduced
767
Closed
502
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$101M |
| 2 |
CVS Health
CVS
|
+$33M |
| 3 |
Uber
UBER
|
+$27.7M |
| 4 |
Booking.com
BKNG
|
+$25.8M |
| 5 |
Medtronic
MDT
|
+$23.2M |
Top Sells
| 1 |
Costco
COST
|
+$23.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$22.9M |
| 3 |
Jabil
JBL
|
+$20.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$19.6M |
| 5 |
Spotify
SPOT
|
+$19.6M |
Sector Composition
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 14.8% |
| 3 | Industrials | 14.69% |
| 4 | Healthcare | 12.33% |
| 5 | Financials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Black Diamond Therapeutics
BDTX
$190M
| $23.8K | ﹤0.01% |
11,143
-7,268
| -39% | -$15.6K |
|
2152
Repare Therapeutics
RPTX
$74.3M
| $23.7K | ﹤0.01% |
18,122
+6,733
| +59% | +$8.82K |
|
|
VIGL
2153
DELISTED
Vigil Neuroscience
VIGL
| $23.3K | ﹤0.01% |
+13,695
| New | +$23.3K |
|
2154
Solarmax Technology
SMXT
$61.4M
| $21.7K | ﹤0.01% |
+13,378
| New | +$21.7K |
|
2155
Galectin Therapeutics
GALT
$366M
| $21.3K | ﹤0.01% |
+16,491
| New | +$21.3K |
|
|
TGB
2156
Taseko Mines
TGB
$1.11B
| $20.4K | ﹤0.01% |
10,493
-34,117
| -76% | -$66.2K |
|
2157
Babcock & Wilcox
BW
$247M
| $19.9K | ﹤0.01% |
12,119
-47,411
| -80% | -$77.8K |
|
2158
Tempest Therapeutics
TPST
$47.7M
| $19.6K | ﹤0.01% |
+1,807
| New | +$19.6K |
|
2159
Karyopharm Therapeutics
KPTI
$56.3M
| $19.4K | ﹤0.01% |
1,913
-1,296
| -40% | -$13.1K |
|
2160
Caribou Biosciences
CRBU
$173M
| $18K | ﹤0.01% |
+11,294
| New | +$18K |
|
|
QMMM
2161
QMMM Holdings Limited Class A Ordinary Shares
QMMM
$5.04B
| $17.6K | ﹤0.01% |
+13,758
| New | +$17.6K |
|
|
ZDAI
2162
Primega Group Holdings Limited Ordinary Shares
ZDAI
$15.5M
| $17.3K | ﹤0.01% |
+12,250
| New | +$17.3K |
|
2163
NextCure
NXTC
$14.3M
| $15.6K | ﹤0.01% |
1,683
+785
| +87% | +$7.26K |
|
2164
Ocugen
OCGN
$331M
| $15.2K | ﹤0.01% |
+18,851
| New | +$15.2K |
|
2165
Origin Materials
ORGN
$80.9M
| $14.5K | ﹤0.01% |
+11,358
| New | +$14.5K |
|
2166
Safety Shot
SHOT
$85.8M
| $13.3K | ﹤0.01% |
+18,438
| New | +$13.3K |
|
2167
Veru
VERU
$53M
| $12.9K | ﹤0.01% |
1,983
-535
| -21% | -$3.48K |
|
2168
ProPhase Labs
PRPH
$21.8M
| $12.1K | ﹤0.01% |
+15,974
| New | +$12.1K |
|
2169
Verrica Pharmaceuticals
VRCA
$47.8M
| $10.8K | ﹤0.01% |
1,538
-124
| -7% | -$868 |
|
2170
Athira Pharma
ATHA
$15.4M
| $9.66K | ﹤0.01% |
16,458
-10
| -0.1% | -$6 |
|
|
MRNS
2171
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.57K | ﹤0.01% |
16,023
-13,459
| -46% | -$7.2K |
|
|
CMLS
2172
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $8K | ﹤0.01% |
11,940
| – | – |
|
2173
5E Advanced Materials
FEAM
$92.5M
| $7.78K | ﹤0.01% |
528
| – | – |
|
2174
BioAtla
BCAB
$40.6M
| $7.58K | ﹤0.01% |
+12,820
| New | +$7.58K |
|
|
KLRS
2175
Kalaris Therapeutics, Inc. Common Stock
KLRS
$79.1M
| $6.77K | ﹤0.01% |
701
+245
| +54% | +$2.37K |
|